CannaTech 2017 - Yuval Landschaft, Director of Medical Cannabis Unit - Israel Ministry of Health
Published on Apr 19, 2017
Enjoy this inspiring address by the Director of the IMCA, the Israeli Medical Cannabis Agency, as he shares where Israel cannabis is headed (hint: it's all about medicalization).
1. This YouTube clip from CannaTech 2017, which BLDV attended, helps us understand how the Israeli GAP and GMP technologies started. See 4:36 for explanation of Cannacopia, 7:57 for GAP and GMP and 11:51 for contacts the Israeli Ministry of Health received from the UN and other nations wanting to see the GCP.
To this end, notice how this aligns with what BLDV stated in the 6/28/17 PR that Medical cannabis standards are being implemented not only in the USA, but also in Europe, Canada and Mexico and the recent 9/8/17 PR that I referred to in my previous post (link back).
2. Note from the BLDV 6/28/17 and 9/8/16 PRs, how BLDV is on the forefront of developments in technology and cannabis practices and standards to be able to state the following in the 6/28/17 PR:
Blue Diamond Ventures Inc. (BLDV) and their wholly owned subsidiary Cannabis-Clean of Denver, will work with existing Israeli Cannabis Farms, Government Regulators, and third-party Certification Agencies to develop Sanitation and Anti-Bacterial protocols that will comply with the newGAP and GMP standards being developed in Israel.
Explanation of Terminology used in Yuval's presentation
Within the Health Ministry, Landschaft told participants how he spearheaded the creation of “the Torah of cannabis” regulation. Landschaft’s “Torah of cannabis,” which he also dubbed “Cannacopia,” contains five sections on Israel Medical Cannabis: IMC-GCP, IMC-GAP, IMC-GMP, IMCGDP and IMC-GSP (Good Clinical Practice, Good Agricultural Practice, Good Manufacturing Practice, Good Delivery Practice and Good Safety Practice).
News 
Market Data 
Discover 
